Ambalal Sarabhai

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE432A01017
  • NSEID: AMBALALSA
  • BSEID: 500009
INR
32.03
-0.54 (-1.66%)
BSENSE

Jun 18

BSE+NSE Vol: 48.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
202.27
196.19
173.57
170.28
196.75
163.64
133.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
202.27
196.19
173.57
170.28
196.75
163.64
133.50
Raw Material Cost
19.21
19.52
15.21
13.08
12.73
12.11
10.08
Purchase of Finished goods
100.13
101.96
83.41
92.16
101.34
86.28
71.43
(Increase) / Decrease In Stocks
-0.20
-5.98
2.40
-2.38
0.64
1.58
-2.17
Employee Cost
32.55
30.70
27.70
25.33
25.30
28.20
27.08
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
-0.01
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
38.82
41.90
38.54
33.52
31.85
37.28
29.27
Total Expenditure (Excl Depreciation)
190.51
188.10
167.26
161.71
171.85
165.44
135.69
Operating Profit (PBDIT) excl Other Income
11.76
8.09
6.31
8.57
24.90
-1.80
-2.19
Other Income
15.17
11.38
10.37
12.49
42.02
30.58
24.39
Operating Profit (PBDIT)
26.93
19.47
16.68
21.06
66.92
28.78
22.20
Interest
4.09
4.26
3.76
2.44
1.70
2.95
3.32
Exceptional Items
-0.82
-7.00
0.00
0.00
-15.11
0.00
0.00
Gross Profit (PBDT)
22.02
8.21
12.92
18.62
50.11
25.83
18.88
Depreciation
3.94
4.01
3.57
2.76
2.32
2.41
2.57
Profit Before Tax
18.09
4.19
9.36
15.86
47.77
23.43
16.32
Tax
0.70
-0.10
0.97
3.72
6.98
3.19
0.88
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.38
4.29
8.39
12.14
40.80
20.24
15.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.38
4.29
8.39
12.14
40.80
20.24
15.44
Share in Profit of Associates
0.42
0.64
-2.71
-0.69
6.42
9.11
-1.38
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.80
4.93
5.68
11.45
47.22
29.36
14.06
Equity Capital
76.63
76.63
76.63
76.63
76.63
76.63
76.63
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
81.72
63.34
60.50
54.29
43.23
-2.74
-31.87
Earnings per share (EPS)
2.32
0.64
0.74
1.49
6.16
3.83
1.83
Diluted Earnings per share
2.32
0.64
0.74
1.45
6.16
3.83
1.83
Operating Profit Margin (Excl OI)
5.81%
4.12%
3.64%
5.03%
12.66%
-1.1%
-1.64%
Gross Profit Margin
10.89%
4.18%
7.44%
10.93%
25.47%
15.78%
14.14%
PAT Margin
8.8%
2.51%
3.27%
6.72%
24.0%
17.94%
10.53%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 3.10% vs 13.03% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 261.05% vs -13.20% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 45.36% vs 28.21% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -3.99% vs 13.30% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Ambalal Sarabhai With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
202.27
0
202.27
Other Operating Income
0.00
0.00
0.00
Total Operating income
202.27
0
202.27
Raw Material Cost
19.21
0
19.21
Purchase of Finished goods
100.13
0
100.13
(Increase) / Decrease In Stocks
-0.20
0
-0.20
Employee Cost
32.55
0
32.55
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
38.82
0.00
38.82
Total Expenditure (Excl Depreciation)
190.51
0
190.51
Operating Profit (PBDIT) excl Other Income
11.76
0.00
11.76
Other Income
15.17
0
15.17
Operating Profit (PBDIT)
26.93
0
26.93
Interest
4.09
0
4.09
Exceptional Items
-0.82
0
-0.82
Gross Profit (PBDT)
22.02
0
22.02
Depreciation
3.94
0
3.94
Profit Before Tax
18.09
0
18.09
Tax
0.70
0
0.70
Provisions and contingencies
0.00
0
0.00
Profit After Tax
17.38
0
17.38
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
17.38
0
17.38
Share in Profit of Associates
0.42
0
0.42
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.80
0
17.80
Equity Capital
76.63
0
76.63
Face Value
10.00
0
0.00
Reserves
81.72
0
81.72
Earnings per share (EPS)
2.32
0
2.32
Diluted Earnings per share
2.32
0
2.32
Operating Profit Margin (Excl OI)
5.81%
0%
0.00
5.81%
Gross Profit Margin
10.89%
0%
0.00
10.89%
PAT Margin
8.80%
0%
0.00
8.80%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 202.27 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 3.10% vs 13.03% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 17.80 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 261.05% vs -13.20% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.76 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 45.36% vs 28.21% in Mar 2025

Annual - Interest
Interest 4.09 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -3.99% vs 13.30% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.81%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025